Abstract: Techniques for triggering pipeline execution based on data change (transaction commit) are described. The pipelines can be used for data ingestion or other specified tasks. These tasks can be operational across account, organization, cloud region, and cloud provider boundaries. The tasks can be triggered by commit post-processing. Gates in the tasks can be set up to reference change data capture information. If the gate is satisfied, tasks can be executed to set up data pipelines.

Abstract: The invention features a replaceable cartridge for a plasma arc torch. The cartridge includes a cartridge body having a first section and a second section. The first and second sections are joined at an interface to form a substantially hollow chamber. The interface provides a coupling force that secures the first and second sections together. The cartridge also includes an arc constricting member located in the second section; an electrode included within the substantially hollow chamber; and a contact start spring element affixed to the electrode. The spring element imparts a separating force that biases the electrode toward at least one of the first section or the second section of the body. The separating force has a magnitude that is less than a magnitude of the coupling force.

Abstract: Contact lenses, methods and systems for accomplishing the requirement for biocompatibility of oxygen delivery to the eye, and the cornea in particular, when elements and components are used which reduce the transmissibility of oxygen and which require coverage of a significant area of the non-vascularized cornea. A contact lens assembly is provided, comprising: an anterior surface, a posterior surface and at least one element or component having a substantially low oxygen permeability disposed within the lens. The contact lens also includes a layer having an oxygen permeability greater than the aforementioned element or component. The thickness of this layer is such that the layer provides an equivalent oxygen percentage to the cornea beneath the aforementioned element or component.

Abstract: Disclosed herein are methods, kits, systems, algorithms and improvements for detecting the presence of or determining an amount, quantity, concentration and/or level of an antibody against at least one type of ?-coronavirus, such as, for example, an antibody against SARS-CoV or SARS-CoV-2, in one or more samples obtained from a subject. In some aspects, the methods, kits and systems relate to detecting the presence of or determining an amount, quantity, concentration and/or level of at least one type of anti-?-coronavirus antibody, such as an IgG and/or IgM antibody, in one or more samples obtained from a subject.

Abstract: A frame is provided, for applying potting material to a printed circuit board (PCB). The frame includes a plurality of substantially vertically oriented walls arranged to isolate a surface of the PCB into a plurality of zones. This allows the frame to be aligned over the surface of the PCB to isolate the surface of the PCB into a plurality of zones, each zone comprising at least one PCB component; and allows the potting material to be applied into the zones to achieve coverage of the PCB components in that zone.

Abstract: The invention relates to solid dispersions of poorly water soluble compounds, in particular Compound A as disclosed herein, formed by solvent co-precipitation or spray drying, resulting in improved bioavailability, safety and tolerability of said compounds.

Abstract: A method and system for handing off a terminal among a plurality of wireless access points (APs) connected to a central management AP. The method comprising: receiving network condition information of a terminal communicatively connected to a first wireless AP among the plurality of wireless APs. Determining a second wireless AP the plurality of wireless APs to which the terminal is to be handed off based on the network condition information of the terminal. The second wireless AP is virtually connected to the terminal. Submitting a handoff request to the second wireless AP. Notifying the terminal to hand off to the second wireless AP in response to receiving a handoff response from the second wireless AP.

Abstract: A method and system for handing off a terminal among a plurality of wireless access points (APs) connected to a central management AP. The method comprising: receiving network condition information of a terminal communicatively connected to a first wireless AP among the plurality of wireless APs. Determining a second wireless AP the plurality of wireless APs to which the terminal is to be handed off based on the network condition information of the terminal. The second wireless AP is virtually connected to the terminal. Submitting a handoff request to the second wireless AP. Notifying the terminal to hand off to the second wireless AP in response to receiving a handoff response from the second wireless AP.

Abstract: The invention relates to solid dispersions of poorly water soluble compounds, in particular Compound A as disclosed herein, formed by solvent co-precipitation or spray drying, resulting in improved bioavailability, safety and tolerability of said compounds.

Abstract: A method and system for handing off a terminal among a plurality of wireless access points (APs) connected to a central management AP. The method comprising: receiving network condition information of a terminal communicatively connected to a first wireless AP among the plurality of wireless APs. Determining a second wireless AP the plurality of wireless APs to which the terminal is to be handed off based on the network condition information of the terminal. The second wireless AP is virtually connected to the terminal. Submitting a handoff request to the second wireless AP. Notifying the terminal to hand off to the second wireless AP in response to receiving a handoff response from the second wireless AP.

Abstract: The invention relates to solid dispersions of poorly water soluble compounds, in particular Compound A as disclosed herein, formed by solvent co-precipitation or spray drying, resulting in improved bioavailability, safety and tolerability of said compounds.

Abstract: A method and system for handing off a terminal among a plurality of wireless access points (APs) connected to a central management AP. The method comprising: receiving network condition information of a terminal communicatively connected to a first wireless AP among the plurality of wireless APs. Determining a second wireless AP the plurality of wireless APs to which the terminal is to be handed off based on the network condition information of the terminal. The second wireless AP is virtually connected to the terminal. Submitting a handoff request to the second wireless AP. Notifying the terminal to hand off to the second wireless AP in response to receiving a handoff response from the second wireless AP.

Abstract: The invention relates to solid dispersions of poorly water soluble compounds, in particular Compound A as disclosed herein, formed by solvent co-precipitation or spray drying, resulting in improved bioavailability, safety and tolerability of said compounds.

Abstract: Provided herein are non-peptide GLP-1 receptor modulator compounds, for example, of Formula I, pharmaceutical compositions comprising such compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of a metabolic disorder.

Abstract: The present invention provides a resin composition consisting of a functionalized polypropylene (PP) and a functionalized styrenic thermoplastic elastomer (TPS). The functionalized PP is a PP grafted with N-vinyl pyrrolidone (NVP) and glycidyl methacrylate (GMA), and the functionalized TPS is a TPS grafted with acrylamide or methacrylamide. The functionalized PP and the functionalized TPS are subjected to melt blending to obtain the resin composition with a slight cross-linking structure due to the reaction between GMA and acrylamide or methacrylamide, therefore the resin composition presents good physical properties. Besides, the resin composition without additional plasticizer or other small molecular organic compounds can be utilized in blood bags, blood transfusion and collection apparatuses, etc. Thus, it does not release small molecular substances which are of potential harm to human body during use.

Abstract: Provided herein are non-peptide GLP-1 receptor modulator compounds, for example, of Formula I, pharmaceutical compositions comprising such compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of a metabolic disorder.

Abstract: The present invention provides a resin composition consisting of a functionalized polypropylene (PP) and a functionalized styrenic thermoplastic elastomer (TPS). The functionalized PP is a PP grafted with N-vinyl pyrrolidone (NVP) and glycidyl methacrylate (GMA), and the functionalized TPS is a TPS grafted with acrylamide or methacrylamide. The functionalized PP and the functionalized TPS are subjected to melt blending to obtain the resin composition with a slight cross-linking structure due to the reaction between GMA and acrylamide or methacrylamide, therefore the resin composition presents good physical properties. Besides, the resin composition without additional plasticizer or other small molecular organic compounds can be utilized in blood bags, blood transfusion and collection apparatuses, etc. Thus, it does not release small molecular substances which are of potential harm to human body during use.

Abstract: Metabolites of a matrix metalloproteinase inhibitor prinomastat and their synthesis. These metabolites are: (3S)-N-hydroxy-4-(4-((1-oxy-pyrid-4-yl)oxy)benzenesulfonyl)-2,2-dimethyl-tetrahydro-2H-1,4-thiazine-3-carboxamide (M6); (3S)-2,2-dimethyl-1,1-dioxo-4-[4-(1-oxy-pyridin-4-yloxy)-benzenesulfonyl]-thiomorpholine-3-carboxylic acid amide (M7); (3S)-2,2-dimethyl-4-[4-(1-oxypyridin-4-yloxy)-benzenesulfonyl]-thiomorpholine-3-carboxylic acid amide (M8); (3S)-2,2-dimethyl-1,1-dioxo-4-[4-(pyridin-4-yloxy)-benzenesulfonyl]-thiomorpholine-3-carboxylic acid amide (M2); and (3S)-2,2-dimethyl-4-[4-(pyridin-4yloxy)-benzenesulfonyl)-thiomorphpline-3-carboxylic acid amide (M3).